Dendrimer‐Triamcinolone Acetonide Reduces Neuroinflammation, Pathological Angiogenesis, and Neuroretinal Dysfunction in Ischemic Retinopathy is a research paper published in Advanced Therapeutics (2020). On theSindex it has a DataRank of 0. It has been cited 36 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30EY001765
NICHD NIH HHS
Grant: R01 HD076901
NEI NIH HHS
Grant: R01 EY022383
NEI NIH HHS
Grant: R01 EY022683
NEI NIH HHS
Grant: R01 EY025304
National Institutes of Health
Grant: 3R01EY022383-01S1
Regulation of diabetic retinopathy by Nrf2
National Institutes of Health
Grant: 5P30EY001765-41
P30 Wilmer Core Grant for Vision Research
National Institutes of Health
Grant: 5R01EY022683-08
Role of Nrf2 in retinal vascularization and ROP
National Institutes of Health
Grant: 1R01EY025304-01
Systemic nanotherapies for ocular inflammation and choroidal neovascularization.
Fields of Study
Keywords
Sustainable Development Goals